![](/img/cover-not-exists.png)
PCN109 REAL-WORLD ADHERENCE, COSTS, AND TREATMENT DOSAGE OF PATIENTS WITH NEUROENDOCRINE TUMORS (NET) TREATED WITH OCTREOTIDE OR LANREOTIDE
Huynh, L., Cai, B., Lejeune, D., Bhak, R., Cheng, M., Lax, A., Duh, M.S., Kim, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.233
Date:
May, 2019
File:
PDF, 383 KB
english, 2019